Home
About
Services
Partners
Client Portfolio
News
Contact
Fiat Chrysler agrees to $800 million U.S. diesel-emissions settlement
January 10, 2019
Trump’s attorney general nominee to recuse from AT&T-Time Warner appeal
January 11, 2019
0
J&J raises U.S. prices on around two dozen drugs
Published by
Muller&Green
at
January 10, 2019
Categories
RSS
Tags
Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more